tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Neuropace, Inc. (NPCE)
NASDAQ:NPCE
US Market
NPCE
NeuroPace
RESEARCH TOOLSreports

NeuroPace (NPCE) Stock News & Sentiment

Compare
136 Followers
NeuroPace: Strong 2025 Execution, Reimbursement Tailwinds, and Label Expansion Upside Support Reiterated Buy and $19 Target
Premium
Ratings
NeuroPace: Strong 2025 Execution, Reimbursement Tailwinds, and Label Expansion Upside Support Reiterated Buy and $19 Target
17d ago
NPCE
Regulatory Shutdowns Threaten Neuropace’s FDA Approvals and Capital Market Access
Premium
Company Announcements
Regulatory Shutdowns Threaten Neuropace’s FDA Approvals and Capital Market Access
18d ago
NPCE
NPCE Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
NPCE Earnings Report this Week: Is It a Buy, Ahead of Earnings?
22d ago
NPCE
NeuroPace Initiated With Buy on Breakthrough RNS Label Expansion Opportunity and Strong NAUTILUS Efficacy Data
Premium
Ratings
NeuroPace Initiated With Buy on Breakthrough RNS Label Expansion Opportunity and Strong NAUTILUS Efficacy Data
3M ago
NPCE
Buy Rating Affirmed on Promising NAUTILUS Trial Results and Potential FDA Consideration
Premium
Ratings
Buy Rating Affirmed on Promising NAUTILUS Trial Results and Potential FDA Consideration
3M ago
NPCE
NeuroPace’s Strong Financial Performance and Strategic Initiatives Justify Buy Rating
Premium
Ratings
NeuroPace’s Strong Financial Performance and Strategic Initiatives Justify Buy Rating
5M ago
NPCE
NeuroPace, Inc. Reports Record Revenue and Growth
Premium
Company Announcements
NeuroPace, Inc. Reports Record Revenue and Growth
5M ago
NPCE
More NPCE News >

NPCE News on the Web

Analysts Are Bullish on These Healthcare Stocks: Kestra Medical Technologies Ltd. (KMTS), NeuroPace (NPCE)
TipRanks News
Bullish
NeuroPace assumed with an Overweight at Wells Fargo
TipRanks News
Bullish
Key Catalysts That Will Likely Drive Prospects for NPCE Stock in 2026
Zacks
Bullish
NPCE RNS System Explained: Growth Drivers and Setup for 2026
Zacks
Bullish
NeuroPace's Seizure ID and New Indication Could Expand RNS Demand
Zacks
Bullish
NeuroPace (NPCE) Receives a Buy from Wells Fargo
TipRanks News
Bullish
NeuroPace: Strong 2025 Execution, Reimbursement Tailwinds, and Label Expansion Upside Support Reiterated Buy and $19 Target
TipRanks News
Bullish
Regulatory Shutdowns Threaten Neuropace’s FDA Approvals and Capital Market Access
TipRanks News
Bearish

News Score - Last 7 Days

Positive
NPCE
Sector Average
Media Buzz
This Week2 articles
Weekly Average5.75 articles
News Sentiment
This Week99%
Sector Average67%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is NPCE’s Media Buzz Sentiment?
2 articles about NPCE were published this week. In an average week, 5.75 articles are published.
    What is NPCE’s weekly average amount of articles?
    In an average week, 5.75 articles about NPCE are published.
      What is NPCE’s News Sentiment?
      99% of articles about NPCE were positive this week, compared to its sector average of 67%.
        Healthcare Stocks that are Trending in the News
        KHTRFKnight Therapeutics
        KMTSKestra Medical Technologies Ltd.
        OVIDOvid Therapeutics
        PYPDPolyPid
        BCYCBicycle Therapeutics
        Showing the stocks with the most bullish news sentiment over the past week